Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
82,216,167
-
Share change
-
+1,668,304
-
Total reported value
-
$1,909,846,504
-
Put/Call ratio
-
0.45%
-
Price per share
-
$23.23
-
Number of holders
-
186
-
Value change
-
+$45,557,038
-
Number of buys
-
80
-
Number of sells
-
100
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2023
As of 31 Mar 2023,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
186 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,216,167 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, EARNEST PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, and Artisan Partners Limited Partnership.
This page lists
186
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.